The prevalence and correlates of urinary tract symptoms in Norwegian men: The HUNT Study

To estimate the prevalence of lower urinary tract symptoms (LUTS) by severity (using the International Prostate Symptom Score, IPSS) in a population‐based study of men aged ≥ 20 years, and to assess the association between putative risk factors and the presence of moderate to severe LUTS.

[1]  P. Boyle,et al.  [Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging.male (MSAM-7)]. , 2003, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

[2]  L. Kiemeney,et al.  The prevalence of lower urinary tract symptoms in men and women in four centres. The UrEpik study , 2003, BJU international.

[3]  Michael A. Joseph,et al.  Risk factors for lower urinary tract symptoms in a population-based sample of African-American men. , 2003, American journal of epidemiology.

[4]  V. Boddi,et al.  Urinary symptoms, quality of life and sexual function in patients with benign prostatic hypertrophy before and after prostatectomy: a prospective study , 2003, BJU international.

[5]  R. Gass.  Benign prostatic hyperplasia: the opposite effects of alcohol and coffee intake , 2002, BJU international.

[6]  J. Dieleman,et al.  Incidence and prevalence of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in primary care--the Triumph project. , 2002, European urology.

[7]  C. la Vecchia,et al.  Knowledge and opinion on prostate and prevalence of self-reported BPH and prostate-related events. A cross-sectional survey in Italy , 2002, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[8]  E. Giovannucci,et al.  Prevalence of and racial/ethnic variation in lower urinary tract symptoms and noncancer prostate surgery in U.S. men. , 2002, Urology.

[9]  G. Castello,et al.  Life-Style in Patients with LUTS Suggestive of BPH , 2001, European Urology.

[10]  M. Barry,et al.  Risk factors for clinical benign prostatic hyperplasia in a community-based population of healthy aging men. , 2001, Journal of clinical epidemiology.

[11]  H. V. van Melick,et al.  Prevalence and bothersomeness of lower urinary tract symptoms in benign prostatic hyperplasia and their impact on well-being. , 2001, The Journal of urology.

[12]  M. Speakman,et al.  Estimating a population's needs for the treatment of lower urinary tract symptoms in men: what is the extent of unmet need? , 2001, Journal of public health medicine.

[13]  J. Ward,et al.  A community study of lower urinary tract symptoms in older men in Sydney, Australia. , 2000, The Australian and New Zealand journal of surgery.

[14]  J. Bosch,et al.  Strong effects of definition and nonresponse bias on prevalence rates of clinical benign prostatic hyperplasia: the Krimpen study of male urogenital tract problems and general health status , 2000, BJU international.

[15]  S. Madersbacher,et al.  Risk Factors for Lower Urinary Tract Symptoms in Elderly Men , 2000, European Urology.

[16]  F. Parazzini,et al.  Prevalence and Risk Factors for Urinary Incontinence in Italy , 2000, European Urology.

[17]  S. Madersbacher,et al.  The prevalence of lower urinary tract symptoms in Austrian males andassociations with sociodemographic variables , 1999, European Journal of Epidemiology.

[18]  E. Rimm,et al.  Alcohol consumption, cigarette smoking, and risk of benign prostatic hyperplasia. , 1999, American journal of epidemiology.

[19]  E. Rimm,et al.  Physical activity and benign prostatic hyperplasia. , 1998, Archives of internal medicine.

[20]  T. Soygür,et al.  The role of cigarette smoking in prostatic enlargement. , 1997, British journal of urology.

[21]  M. Stampfer,et al.  A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer. , 1995, JAMA.

[22]  J. Oesterling,et al.  Cigarette smoking and prostatism: a biphasic association? , 1994, Urology.

[23]  J. Oesterling,et al.  The prevalence of prostatism: a population-based survey of urinary symptoms. , 1993, The Journal of urology.

[24]  R C Bruskewitz,et al.  Correlation of the American Urological Association symptom index with self-administered versions of the Madsen-Iversen, Boyarsky and Maine Medical Assessment Program symptom indexes. Measurement Committee of the American Urological Association. , 1992, The Journal of urology.

[25]  A. Morrison.  Risk factors for surgery for prostatic hypertrophy. , 1992, American journal of epidemiology.

[26]  S. Sidney,et al.  Risk factors for surgically treated benign prostatic hyperplasia in a prepaid health care plan. , 1991, Urology.

[27]  L. Stovner,et al.  High systolic blood pressure is associated with Val/Val genotype in the catechol-o-methyltransferase gene. The Nord-Trøndelag Health Study (HUNT). , 2007, American journal of hypertension.

[28]  Arnulf Langhammer,et al.  The Nord-Trøndelag Health Study 1995-97 (HUNT 2): Objectives, contents, methods and participation , 2003 .

[29]  H. Guess.  Benign prostatic hyperplasia and prostate cancer. , 2001, Epidemiologic reviews.

[30]  T. Tammela,et al.  Association of non-urological diseases with lower urinary tract symptoms. , 2001, Scandinavian journal of urology and nephrology.

[31]  P. Boyle,et al.  International comparison of the community prevalence of symptoms of prostatism in four countries. , 1996, European urology.